Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP529161.RA-jQunquPcqMcMgio4Ke3R-GP1w5ZQpz-pZmeXZvD2g8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP529161.RA-jQunquPcqMcMgio4Ke3R-GP1w5ZQpz-pZmeXZvD2g8130_assertion type Assertion NP529161.RA-jQunquPcqMcMgio4Ke3R-GP1w5ZQpz-pZmeXZvD2g8130_head.
- NP529161.RA-jQunquPcqMcMgio4Ke3R-GP1w5ZQpz-pZmeXZvD2g8130_assertion description "[Subsequent application of a tri-panel of CK14, EGFR and 34 beta E12 (specificity 100% and sensitivity 78%) to our group of 653 triple-negative breast cancers delineated 84% to be basal-like.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP529161.RA-jQunquPcqMcMgio4Ke3R-GP1w5ZQpz-pZmeXZvD2g8130_provenance.
- NP529161.RA-jQunquPcqMcMgio4Ke3R-GP1w5ZQpz-pZmeXZvD2g8130_assertion evidence source_evidence_literature NP529161.RA-jQunquPcqMcMgio4Ke3R-GP1w5ZQpz-pZmeXZvD2g8130_provenance.
- NP529161.RA-jQunquPcqMcMgio4Ke3R-GP1w5ZQpz-pZmeXZvD2g8130_assertion SIO_000772 19855377 NP529161.RA-jQunquPcqMcMgio4Ke3R-GP1w5ZQpz-pZmeXZvD2g8130_provenance.
- NP529161.RA-jQunquPcqMcMgio4Ke3R-GP1w5ZQpz-pZmeXZvD2g8130_assertion wasDerivedFrom befree-20150227 NP529161.RA-jQunquPcqMcMgio4Ke3R-GP1w5ZQpz-pZmeXZvD2g8130_provenance.
- NP529161.RA-jQunquPcqMcMgio4Ke3R-GP1w5ZQpz-pZmeXZvD2g8130_assertion wasGeneratedBy ECO_0000203 NP529161.RA-jQunquPcqMcMgio4Ke3R-GP1w5ZQpz-pZmeXZvD2g8130_provenance.